Future of Cannabis & AI

The cannabis industry is in the middle of a regulatory and technological transition. Federal rescheduling proposals, banking reform efforts, and the integration of artificial intelligence across cultivation and retail are reshaping how cannabis is grown, sold, and understood. These are not projections — they are processes already underway with measurable effects on the market.

The gap between where the industry is and where it is heading has narrowed significantly since 2020. The policy questions that once seemed distant — federal reclassification, interstate commerce, banking access — are now active legislative and regulatory matters. Simultaneously, technology that was peripheral three years ago is becoming central to how licensed operators run their businesses. For context on how product evaluation fits into this evolving landscape, see the TGC overview of how TGC grades cannabis.

Federal Rescheduling: What the DEA Proposal Actually Means

In 2024, the Drug Enforcement Administration (DEA) formally proposed rescheduling cannabis from Schedule I to Schedule III under the Controlled Substances Act. The proposal followed a recommendation from the Department of Health and Human Services (HHS) and represents the first formal federal reclassification attempt in the history of modern cannabis policy.

Schedule III status would have concrete, immediate financial implications for the cannabis industry. IRS Section 280E, which currently prevents cannabis businesses from deducting ordinary operating expenses on federal taxes, applies only to Schedule I and II substances. Rescheduling to Schedule III would remove this restriction, allowing licensed cannabis companies to deduct payroll, rent, marketing, and other standard business expenses. For an industry carrying some of the highest effective tax rates of any legal sector, this is a material change — not a symbolic one.

What rescheduling to Schedule III would not do is legalize adult-use cannabis at the federal level. Schedule III substances remain controlled — they are subject to federal regulation, prescription requirements in clinical contexts, and DEA oversight. The reclassification would not create a federal framework for recreational retail or resolve the conflict between state and federal law for adult-use markets. It is a regulatory step, not a legalization event.

Banking and Financial Infrastructure

Cannabis businesses in legal states have operated under a structural disadvantage since state markets opened: federal prohibition makes most financial institutions unwilling to provide banking services to plant-touching cannabis companies without significant legal exposure. The result has been an industry that operates disproportionately in cash — which creates security risks, complicates payroll and tax compliance, and raises operational costs.

The SAFE Banking Act (Secure and Fair Enforcement Banking Act) has been introduced in multiple Congressional sessions and passed the House of Representatives multiple times with bipartisan support. As of 2024, it had not passed the Senate. The Act would provide a safe harbor for financial institutions serving licensed cannabis businesses, allowing standard banking relationships without federal regulatory exposure.

Without SAFE Banking passage or equivalent legislation, most cannabis businesses continue to rely on cash, credit unions willing to accept the legal risk, or state-chartered banks operating under state-level frameworks. The financial infrastructure gap is one of the most operationally significant ongoing consequences of federal Schedule I status.

AI in Cannabis Cultivation

Artificial intelligence is being applied to cannabis cultivation in ways that move the industry away from intuition-based growing and toward data-driven crop management. The scale and specificity of these applications have expanded considerably as cultivation facilities have added sensor arrays, computer vision systems, and automated climate infrastructure.

• Computer vision for disease and pest detection. Machine learning systems trained on large image datasets can identify early signs of fungal infection, nutrient deficiency, pest damage, and water stress in cannabis plants before the conditions are visible to the human eye. Early detection allows intervention before a problem spreads across a crop.
• Automated climate control. AI-driven environmental management systems continuously monitor and adjust temperature, humidity, CO2 levels, and light intensity based on real-time sensor data and predictive models. These systems reduce energy consumption and maintain tighter control over growing conditions than manual or timer-based approaches.
• Yield prediction. Predictive models using historical grow data, current environmental parameters, and genetic information from specific cultivars are being used to forecast yield and potency before harvest. This improves inventory planning and financial forecasting for multi-facility operators.
• Terpene and cannabinoid profile prediction. AI tools that analyze genetic markers and growing environment data to predict likely cannabinoid and terpene outcomes are emerging as breeding tools. Cannabis breeders are using these models to identify genetics likely to express target profiles before committing to a full grow cycle.

AI in Retail and Consumer Technology

At the retail level, AI applications are changing how dispensaries interact with consumers and how consumers access information about products.

• Personalized product recommendations. Dispensary platforms and point-of-sale systems are increasingly incorporating algorithms that map consumer purchase history and stated effect preferences to product attributes — cannabinoid ratios, terpene profiles, format, and potency — to surface relevant options.
• Lab data interpretation tools. As Certificate of Analysis (COA) data becomes more standardized across state markets, consumer-facing tools are being developed to translate laboratory results into accessible guidance. Instead of reading raw percentages, consumers can receive structured interpretations of what a product’s profile suggests about its likely effect characteristics.
• Blockchain supply chain tracking. Blockchain-based seed-to-sale tracking systems are being piloted by state regulators and operators to create an immutable, auditable record of a product’s journey from cultivation through retail, enhancing supply chain transparency and supporting compliance verification.

Pricing transparency is also advancing through third-party data tools. Tools like the CannabisDealsUS Cannabis Price Index are making pricing more transparent, giving consumers a benchmark for evaluating what they pay relative to market norms rather than relying solely on in-store price comparisons.

Market Scale and Standardization

The U.S. cannabis market is projected to exceed $45 billion annually by 2025 across multiple industry analyses. That scale has created pressure for standardization in areas where the industry previously operated with significant inconsistency — testing methodology, potency labeling, product categorization, and safety thresholds.

State-by-state testing requirements have historically varied enough to make interstate product comparisons unreliable. As more states establish markets and as federal rescheduling discussions progress, there is increasing regulatory and industry interest in harmonizing testing standards. Standardized testing would make COA data more meaningful across jurisdictions and give consumers more confidence in labeled potency and safety information.

The convergence of laboratory science and retail data tools is producing a more information-rich consumer environment than existed even five years ago. Consumers in legal markets now routinely access terpene profiles, cannabinoid ratios, and third-party test results that were not standard retail information at the time early markets opened. As data infrastructure matures, the gap between what producers know about a product and what consumers can access is narrowing.

Practical Implications

• Federal rescheduling progress will affect pricing. If 280E tax deductions become available to cannabis businesses, the reduction in effective tax burden has the potential to reduce wholesale and retail prices over time as market economics adjust.
• Banking reform would increase retail access and options. Broader banking access would enable cannabis businesses to accept credit and debit cards more reliably and expand delivery and subscription models that currently face payment processing barriers.
• Lab data will become more actionable. As testing standardization advances and consumer-facing interpretation tools improve, the information available at point of purchase will support more informed product selection based on chemistry rather than brand or label language alone.
• Price benchmarking tools are available now. Consumers do not need to wait for future developments to access pricing transparency — third-party price indices already provide market benchmarks across multiple state markets.

---

Browse Cannabis Price Index at CannabisDealsUS.